22 June 2020
Sechenov First Moscow State Medical University (Sechenov University) has launched clinical trials of a vaccine against coronavirus. Eighteen volunteers have been vaccinated, Director of the university’s Institute for Translational Medicine and Biotechnology, Vadim Tarasov, said on June 18.
Study of a vaccine against the coronavirus infection was launched at sechenov university of the russian ministry of health. Thirty-eight volunteers take part in it, of whom 18 were vaccinated today. The vaccination of another 20 people is scheduled for the next week,” the press service of the ministry of health cited him as saying.
The volunteers will remain at a clinic of the university’s Center of Interventional Cardio-Angiology within 28 days under the control of medics. The male and female participants are aged 18 to 65 and come from different Russian cities. The vaccination is carried out with their written consent and with the compliance with all requirements of the Russian law and international rules of ethics.
“It is very important for us to study how efficiently the immunity develops. If after the vaccination the person remains in their habitual environment, a high risk remains amid the pandemic, and later it will be impossible to say what caused the immunity — the disease or the vaccine. For this, the volunteers stay at a clinic within 28 days, where they are isolated from other social contacts,” the press service quotes Tarasov as saying.
Results of the clinical trials of the novel coronavirus vaccine, developed by the Gamalei National Research Center for Epidemiology and Microbiology, are expected by August. Then the ministry will assess the results and will decide on whether it will be possible to use the vaccine.Print
06 July 2020
03 July 2020
03 July 2020
02 July 2020